Azioni Innovus Pharmaceuticals Inc Other OTC
Azioni
US45778V1061
Prodotti farmaceutici
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01/06/18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Variaz. 1 gen. | Capi. | |
---|---|---|
+29,95% | 684 Mrd | |
+30,34% | 568 Mrd | |
-3,80% | 361 Mrd | |
+18,24% | 329 Mrd | |
+3,94% | 284 Mrd | |
+16,21% | 240 Mrd | |
+9,66% | 208 Mrd | |
-6,83% | 200 Mrd | |
+7,08% | 166 Mrd |